adplus-dvertising
Connect with us

Business

3.5 million Canadian adults have had long COVID symptoms: StatCan study

Published

 on

COVID can cause damage to organs and the vascular system. But can it also damage our immune systems, increasing our chances of getting sick with other infections?

New data show millions of Canadians have experienced symptoms of long COVID, with some still suffering from debilitating side effects a year or more after being infected.

In some cases, long COVID could be down to a “compromised” immune system, scientists say, which has other people asking whether COVID might be increasing our chances of getting sick with other infections.

About 3.5 million Canadians have experienced fatigue, brain fog, shortness of breath and other lingering symptoms for three months or longer after a confirmed or suspected COVID infection “that could not be explained by anything else,” according to a national study.

As of this past June, more than half — 2.1 million people — were still experiencing symptoms, 11 months, on average, after their last known encounter with SARS-CoV-2.

The more infections, the more likely people were to be hit with long-term problems, from mild to debilitating. People missed, on average, 24 days of work or school, adding up to a cumulative total of about 14.5 million missed work or school days.

“As of June 2023, about 100,000 Canadian adults have been unable to return to work or school because of their symptoms,” according to the survey by Statistics Canada and the Public Health Agency of Canada.

The findings fit with Dr. Manali Mukherjee’s personal and professional experience. It took 18 months for the McMaster University immunologist to recover from long COVID.

Science is still struggling to sort out what, exactly, defines long COVID, or the “post COVID” condition, or how to treat which patients with what drugs. More than 100 symptoms spanning virtually every organ system have been reported, from abdominal pain and hair loss to problems concentrating.

The problem has been pinned on rogue autoantibodies that turn on the body’s own tissues, attacking the “host,” or overactive cytokines, proteins that boost inflammation as part of the body’s natural immune response. “Cytokines give us an idea that there is still inflammation going on,” Mukherjee said.

The new study is an update to preliminary findings released last summer on the ongoing experiences of COVID in Canadian adults more than three years after the start of the pandemic.

The findings are consistent with other international studies, including a recent study published in Nature Medicine that found increased risks of cardiovascular issues, diabetes, lung problems, gut problems, blood clots and other conditions up to two years later, after even mild or moderate COVID infections.

“A lot of people think, ‘I got COVID, I got over it and I’m fine, and it’s a nothingburger for them. But that’s not everything,” the study’s senior author, Ziyad Al-Aly, a Washington University School of Medicine clinical epidemiologist told the Washington Post. For some people, “it’s still wreaking havoc in your body.”

The Nature Medicine study was based on the health records of U.S. military veterans (most of them men) who were infected before vaccines and drugs like Paxlovid, the antiviral pill used to treat COVID-19, became available.

COVID is known to cause damage to organs and the vascular system in some people. And some doctors have again raised the spectre, recently amplified on social media, that COVID “damages the immune system,” rendering people more susceptible to other respiratory viruses or pathogens, a claim several of Canada’s leading experts in virology and immunology say is speculative rhetoric that exaggerates COVID’s risks.

Like other respiratory bugs, COVID-19 can lead to “temporary perturbation” in the immune system, “but not what can be considered a truly immunocompromised state,” said Mark Loeb, a professor of pathology and molecular medicine at McMaster University.

COVID can cause immunological changes that can be measured with sophisticated techniques. Whether those changes are meaningful is an important question worthy of careful study, said Matthew Miller, director of McMaster’s Michael G. DeGroote Institute for Infectious Disease Research.

“It’s not that I don’t believe it is possible that COVID might, in some cases, cause immune deficiency — it’s simply that there is not currently sufficient evidence to conclude that it happens,” Miller said in an email.

“Is getting infected good for you? Of course not. Should we take steps to prevent infection? Absolutely!

“But rhetoric that overstates the current state of evidence related to COVID risks is no more valid than rhetoric that diminishes the seriousness of COVID-19.”

On X, formerly Twitter, Dr. Lisa Iannattone, an assistant professor of dermatology at McGill University, said COVID “immune damage” could be contributing to recent surges in RSV and other respiratory infections.

Iannattone cited a recent study that found a prior COVID infection was associated with a 40 per cent increased risk of an RSV infection needing medical attention in children during the 2021 and 2022 RSV seasons.

“The study shows that the terrible 2022 RSV epidemic was not as simple as a ‘catch up” year,” Iannattone said in the thread. “The 2022 surge was driven by ‘more severe cases.’ What happened between 2021 and 2022? Mass infection of children with Omicron.”

Another study this year reported a higher risk of shingles in the 12 months after a COVID infection, while an Israeli team reported a higher risk of streptococcal tonsilitis, among other conditions, a year after a mild case of COVID.

“It’s hard to make any firm conclusions,” Iannattone said in an interview with National Post. “My concern is that at least a subset of people do seem to be having this period, post infection, where their immune system is dysregulated.”

“It’s difficult to understand why we wouldn’t be throwing that in as one of the main hypotheses of things that could be contributing to what we’re seeing,” she said.

Loeb said the early RSV surges “had nothing to do with some sort of global immune dysfunction.” Rather, many children were seeing RSV for the first time, all at once, after being sheltered by lockdowns, physical distancing and other measures during the pandemic’s earlier waves.

“I do think there are post-inflammatory changes that occur with COVID-19 that can persist for weeks, perhaps months,” Loeb said. “And there could be symptoms that persist.” But that’s not unique to COVID, he said. “These post-viral symptoms are also seen in influenza and likely other viruses,” Loeb said.

It can take weeks to clear all infected cells from the body, said University of Ottawa molecular virologist Marc-André Langlois. Some cells might also contain bits of the viral genome that can trigger inflammation.

“As it stands, I would be cautious to make claims that these observations are unique to COVID, and I would at this time avoid using words such as ‘immune threat’ or ‘immune dysfunction’ until there is more evidence,” Langlois said in an email.

A subset of people with long COVID do appear to have immune systems that are “a little compromised,” leading to that malaise and fatigue, Mukherjee said.

While most symptoms clear within a year, “We’re still dealing with the aftermath of COVID,” she said.

About one in nine of all Canadian adults have experienced long-term symptoms from a COVID infection, reported the StatCan study.

Few people, only one in eight, who sought care for lingering symptoms felt it was adequate care.

Some people still question just how debilitating long COVID can be, or whether it’s a true phenomenon, said Mukherjee, who struggled with staggering fatigue, sudden plummeting blood pressure and phantosmia, where people smell “phantom” odours that aren’t there.

“I’ve been pacing myself,” she said. “That’s helped me not have a relapse, thus far.”

728x90x4

Source link

Continue Reading

Business

Canada Goose to get into eyewear through deal with Marchon

Published

 on

 

TORONTO – Canada Goose Holdings Inc. says it has signed a deal that will result in the creation of its first eyewear collection.

The deal announced on Thursday by the Toronto-based luxury apparel company comes in the form of an exclusive, long-term global licensing agreement with Marchon Eyewear Inc.

The terms and value of the agreement were not disclosed, but Marchon produces eyewear for brands including Lacoste, Nike, Calvin Klein, Ferragamo, Longchamp and Zeiss.

Marchon plans to roll out both sunglasses and optical wear under the Canada Goose name next spring, starting in North America.

Canada Goose says the eyewear will be sold through optical retailers, department stores, Canada Goose shops and its website.

Canada Goose CEO Dani Reiss told The Canadian Press in August that he envisioned his company eventually expanding into eyewear and luggage.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GOOS)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

TD CEO to retire next year, takes responsibility for money laundering failures

Published

 on

 

TORONTO – TD Bank Group, which is mired in a money laundering scandal in the U.S., says chief executive Bharat Masrani will retire next year.

Masrani, who will retire officially on April 10, 2025, says the bank’s, “anti-money laundering challenges,” took place on his watch and he takes full responsibility.

The bank named Raymond Chun, TD’s group head, Canadian personal banking, as his successor.

As part of a transition plan, Chun will become chief operating officer on Nov. 1 before taking over the top job when Masrani steps down at the bank’s annual meeting next year.

TD also announced that Riaz Ahmed, group head, wholesale banking and president and CEO of TD Securities, will retire at the end of January 2025.

TD has taken billions in charges related to ongoing U.S. investigations into the failure of its anti-money laundering program.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending